Cargando…
pH-Responsive Release of Ruthenium Metallotherapeutics from Mesoporous Silica-Based Nanocarriers
Ruthenium complexes are attracting interest in cancer treatment due to their potent cytotoxic activity. However, as their high toxicity may also affect healthy tissues, efficient and selective drug delivery systems to tumour tissues are needed. Our study focuses on the construction of such drug deli...
Autores principales: | Mladenović, Minja, Morgan, Ibrahim, Ilić, Nebojša, Saoud, Mohamad, Pergal, Marija V., Kaluđerović, Goran N., Knežević, Nikola Ž. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067187/ https://www.ncbi.nlm.nih.gov/pubmed/33800647 http://dx.doi.org/10.3390/pharmaceutics13040460 |
Ejemplares similares
-
Mesoporous Silica Nanoparticles Enhance the Anticancer Efficacy of Platinum(IV)-Phenolate Conjugates in Breast Cancer Cell Lines
por: Predarska, Ivana, et al.
Publicado: (2022) -
Applications and Biocompatibility of Mesoporous Silica Nanocarriers in the Field of Medicine
por: Zhang, Chengcheng, et al.
Publicado: (2022) -
Mesoporous silica nanocarriers encapsulated antimalarials with high therapeutic performance
por: Amolegbe, Saliu Alao, et al.
Publicado: (2018) -
Anticancer Potential of Xanthohumol and Isoxanthohumol Loaded into SBA-15 Mesoporous Silica Particles against B16F10 Melanoma Cells
por: Krajnović, Tamara, et al.
Publicado: (2022) -
Drug Delivery System for Emodin Based on Mesoporous Silica SBA-15
por: Krajnović, Tamara, et al.
Publicado: (2018)